# Atea Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 28, 2023

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: DEF 14A
- Filed: 2023-04-28
- Accepted by EDGAR: Apr 28, 2023, 20:07 ET
- Period: not reported
- Accession: 0000950170-23-015773
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000095017023015773/avir-20230428.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000095017023015773/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000095017023015773/avir-20230428.htm

Filed Apr 28, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-015773. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.